Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dillon Capital refers to two closely related boutique advisory firms: Dillon Capital Strategies specializes in strategy consulting for the business side of drug/device/diagnostic development and partnering. It provides services such as opportunity search/screening for deals/licensing/M&A across all therapeutic areas within biopharma and medtech. It leverages decades of executive experience to support clients with valuation models and interim management roles. Dillon Capital LLC focuses on advising/investing in private/micro-cap public companies within health/wellness/longevity sectors globally. It emphasizes “skin in the game” by investing its own capital alongside clients. Neither develops drugs/devices themselves; both serve innovators through strategic advice/investment support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dillon Capital.